Fig. 2
From: Investigation of the synergistic effect of metformin and FX11 on PANC-1 cell lines
Effects of drug combinations on viability. M: metformin; M1: 0.1 mM (low-dose) metformin; M2: 10 mM (effective-dose) metformin. F: FX11 agents; F1: 2.5 µM (low-dose), F2: 7.5 µM (intermediate-dose), F3: 20 µM (effective-dose). DMSO: Control group. Experiments were performed in triplicate (n = 3). Statistical significance: p < 0.05